Suggestions
Ronald Weidner
Founder at Vive Benefits
Ronald Weidner: Serial Entrepreneur and Thought Leader
Ronald Weidner is a serial entrepreneur and thought leader with over four decades of global experience across healthcare, financial services, real estate, and artificial intelligence.1 He has navigated through pivotal moments in recent history, from the financial sector's tumultuous shifts in the 1980s to the rise of the developing world and the technological innovations in Silicon Valley.1
Current Roles
- Managing Principal at emPower LLC, a company that envisions a world where artificial intelligence seamlessly integrates into real estate, financial services, and healthcare1
- Healthcare Transformer at StartUp Health, a global entrepreneurship development company for Healthcare Transformers1
- Managing Principal at PLB Capital Partners, a family office that channels personal and family wealth into ventures that advance societal health, economic stability, and environmental sustainability1
- Founder of the ULI Greenprint Center, a not-for-profit global organization established to enable major owners, managers and operators of commercial and residential real estate to collaborate on reducing greenhouse gas emissions in the built environment1
Past Experience
- Founder & President of Vive Benefits, a company founded in response to the rising trend of employer-sponsored high deductible health plans (HDHPs) and their unintended consequences for individuals123
- Global Chief Investment Officer Real Estate at Allianz, where he increased the investment portfolio to €30 billion1
- Managing Partner at KanAm Grund Group1
Ronald Weidner's LinkedIn profile can be found at https://www.linkedin.com/in/ronald-weidner-08045715.1
Highlights
Dec 19 · instantcheckmate.com
Ronald Weidner Found! - See Phones, Email, Addresses, and More
Nov 27 · MedCity News
International accelerator grows digital health cohort in Miami - MedCity News
Jan 15 · MedCity News
Here's a look at StartUp Health's latest additions from treating chronic pain to teledermatology - MedCity News